Skip to main content

Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes.

Publication ,  Journal Article
Diwan, A; Dibbs, Z; Nemoto, S; DeFreitas, G; Carabello, BA; Sivasubramanian, N; Wilson, EM; Spinale, FG; Mann, DL
Published in: Circulation
January 20, 2004

BACKGROUND: Recent studies suggest that posttranslation processing or "shedding" (ie, secretion) of tumor necrosis factor (TNF) by tumor necrosis factor-alpha converting enzyme (TACE) may contribute to the left ventricular (LV) remodeling that occurs in the failing human heart. METHODS AND RESULTS: To address the functional significance of TNF shedding, we generated lines of transgenic mice with targeted overexpression of secreted wild-type (MHCsTNF2) TNF and overexpression of a mutated noncleavable transmembrane form of TNF (MHCmTNF). Both lines of mice had overlapping levels of myocardial TNF protein; however, the phenotypes of the MHCsTNF2 and MHCmTNF mice were strikingly disparate. Whereas the MHCmTNF mice developed a concentric LV hypertrophy phenotype, the MHCsTNF2 mice developed a dilated LV phenotype. The fibrillar collagen weave in MHCmTNF mice with concentric hypertrophy was characterized by thick collagen fibrils and increased collagen content, whereas the fibrillar collagen weave in the MHCsTNF2 mice with LV dilation was characterized by a diminished collagen content. Inhibition of matrix metalloproteinases with a broad-based matrix metalloproteinase inhibitor prevented LV dilation in the MHCsTNF2 mice. CONCLUSIONS: These findings suggest that posttranslational processing of TNF, as opposed to TNF expression per se, is responsible for the adverse cardiac remodeling that occurs after sustained TNF overexpression.

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 20, 2004

Volume

109

Issue

2

Start / End Page

262 / 268

Location

United States

Related Subject Headings

  • Ventricular Remodeling
  • Tumor Necrosis Factor-alpha
  • Tissue Inhibitor of Metalloproteinases
  • Phenotype
  • Myocardium
  • Mutation
  • Mice, Transgenic
  • Mice
  • Matrix Metalloproteinases
  • Matrix Metalloproteinase Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Diwan, A., Dibbs, Z., Nemoto, S., DeFreitas, G., Carabello, B. A., Sivasubramanian, N., … Mann, D. L. (2004). Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. Circulation, 109(2), 262–268. https://doi.org/10.1161/01.CIR.0000109642.27985.FA
Diwan, Abhinav, Ziad Dibbs, Shintaro Nemoto, Gilberto DeFreitas, Blase A. Carabello, Natarajan Sivasubramanian, Eric M. Wilson, Francis G. Spinale, and Douglas L. Mann. “Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes.Circulation 109, no. 2 (January 20, 2004): 262–68. https://doi.org/10.1161/01.CIR.0000109642.27985.FA.
Diwan A, Dibbs Z, Nemoto S, DeFreitas G, Carabello BA, Sivasubramanian N, et al. Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. Circulation. 2004 Jan 20;109(2):262–8.
Diwan, Abhinav, et al. “Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes.Circulation, vol. 109, no. 2, Jan. 2004, pp. 262–68. Pubmed, doi:10.1161/01.CIR.0000109642.27985.FA.
Diwan A, Dibbs Z, Nemoto S, DeFreitas G, Carabello BA, Sivasubramanian N, Wilson EM, Spinale FG, Mann DL. Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. Circulation. 2004 Jan 20;109(2):262–268.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 20, 2004

Volume

109

Issue

2

Start / End Page

262 / 268

Location

United States

Related Subject Headings

  • Ventricular Remodeling
  • Tumor Necrosis Factor-alpha
  • Tissue Inhibitor of Metalloproteinases
  • Phenotype
  • Myocardium
  • Mutation
  • Mice, Transgenic
  • Mice
  • Matrix Metalloproteinases
  • Matrix Metalloproteinase Inhibitors